View Financial HealthGridAI Technologies 配当と自社株買い配当金 基準チェック /06GridAI Technologies配当金を支払った記録がありません。主要情報n/a配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • May 16GridAI Technologies Corp. announced delayed 10-Q filingOn 05/15/2026, GridAI Technologies Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Apr 29GridAI Technologies Corp. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K FilingOn April 22, 2026, GridAI Technologies Corp. (the Company) received a letter (the Letter) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (Nasdaq) indicating that the Company was not in compliance with the filing of periodic financial reports requirement for continued listing on The Nasdaq Capital Market, under Listing Rule 5250(c)(1), because the Company has not yet filed its 10-K for the period ended December 31, 2025. The Company has 60 calendar days from April 22, 2026, or through June 22, 2026, to submit to Nasdaq a plan to regain compliance with Listing Rule 5250(c)(1). If Nasdaq accepts the Company's plan, Nasdaq may grant an extension of up to 180 calendar days from April 15, 2026, or through October 12, 2026, to regain compliance. If Nasdaq does not accept the Company's plan, the Company will have the right to appeal such decision to a Nasdaq hearings panel. The delay in filing the Company's Annual Report on Form 10-K is due to the complexity in reviewing the accounting treatment and other information related to the Company's recent acquisition of Grid AI Corp. The Company intends to file its Annual Report on Form 10-K as soon as possible, and to submit to Nasdaq, within the requisite time period, a plan to regain compliance with Listing Rule 5250(c)(1). There can be no assurance that Nasdaq will accept the Company's plan or that the Company will be able to regain compliance with Listing Rule 5250(c)(1) or maintain compliance with any other Nasdaq requirement in the future. The Company, by filing this Form 8-K, discloses its receipt of the notification from Nasdaq in accordance with Listing Rule 5810(b).お知らせ • Apr 01GridAI Technologies Corp. announced delayed annual 10-K filingOn 03/31/2026, GridAI Technologies Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Mar 17GridAI Technologies Corp. has withdrawn its Follow-on Equity Offering in the amount of $6 million.GridAI Technologies Corp. has withdrawn its Follow-on Equity Offering in the amount of $6 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 12,000,000 Price\Range: $0.5 Discount Per Security: $0.02 Security Name: Pre-funded Warrants Security Type: Equity Warrant Securities Offered: 12,000,000Board Change • Feb 17Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Lead Independent Director Ed Borkowski was the last independent director to join the board, commencing their role in 2015. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Dec 05+ 1 more updateGridAI Technologies Corp. Announces Board and Committee ChangesGridAI Technologies Corp. announced on November 28, 2025, Mr. Eric Corbett notified the Company of his resignation as a director of the company. On November 28, 2025, Mr. Richard Paolone notified the Company of his resignation as a director of the Company. Pursuant to the resignations of directors discussed in this Item 5.02, the committees of the Board of Directors of the Company shall comprise of the following: Audit Committee: (i) Ed Borkowski (Chair and Audit Committee Financial Expert); (ii) Manpreet Uppal; and (iii) Geordan G. Pursglove. Compensation Committee: (i) Ed Borkowski (Chair); (ii) Manpreet Uppal; and (iii) Geordan G. Pursglove.お知らせ • Nov 18Entero Therapeutics, Inc. announced delayed 10-Q filingOn 11/17/2025, Entero Therapeutics, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.決済の安定と成長配当データの取得安定した配当: GRDXの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: GRDXの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場GridAI Technologies 配当利回り対市場GRDX 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (GRDX)n/a市場下位25% (US)1.4%市場トップ25% (US)4.3%業界平均 (Biotechs)2.4%アナリスト予想 (GRDX) (最長3年)n/a注目すべき配当: GRDXは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: GRDXは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: GRDXの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: GRDXが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YUS 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/17 23:29終値2026/05/15 00:00収益N/A年間収益N/Aデータソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋GridAI Technologies Corp. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 16GridAI Technologies Corp. announced delayed 10-Q filingOn 05/15/2026, GridAI Technologies Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 29GridAI Technologies Corp. Announces Receipt of Nasdaq Notice Regarding Late Form 10-K FilingOn April 22, 2026, GridAI Technologies Corp. (the Company) received a letter (the Letter) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (Nasdaq) indicating that the Company was not in compliance with the filing of periodic financial reports requirement for continued listing on The Nasdaq Capital Market, under Listing Rule 5250(c)(1), because the Company has not yet filed its 10-K for the period ended December 31, 2025. The Company has 60 calendar days from April 22, 2026, or through June 22, 2026, to submit to Nasdaq a plan to regain compliance with Listing Rule 5250(c)(1). If Nasdaq accepts the Company's plan, Nasdaq may grant an extension of up to 180 calendar days from April 15, 2026, or through October 12, 2026, to regain compliance. If Nasdaq does not accept the Company's plan, the Company will have the right to appeal such decision to a Nasdaq hearings panel. The delay in filing the Company's Annual Report on Form 10-K is due to the complexity in reviewing the accounting treatment and other information related to the Company's recent acquisition of Grid AI Corp. The Company intends to file its Annual Report on Form 10-K as soon as possible, and to submit to Nasdaq, within the requisite time period, a plan to regain compliance with Listing Rule 5250(c)(1). There can be no assurance that Nasdaq will accept the Company's plan or that the Company will be able to regain compliance with Listing Rule 5250(c)(1) or maintain compliance with any other Nasdaq requirement in the future. The Company, by filing this Form 8-K, discloses its receipt of the notification from Nasdaq in accordance with Listing Rule 5810(b).
お知らせ • Apr 01GridAI Technologies Corp. announced delayed annual 10-K filingOn 03/31/2026, GridAI Technologies Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Mar 17GridAI Technologies Corp. has withdrawn its Follow-on Equity Offering in the amount of $6 million.GridAI Technologies Corp. has withdrawn its Follow-on Equity Offering in the amount of $6 million. Security Name: Common Stock Security Type: Common Stock Securities Offered: 12,000,000 Price\Range: $0.5 Discount Per Security: $0.02 Security Name: Pre-funded Warrants Security Type: Equity Warrant Securities Offered: 12,000,000
Board Change • Feb 17Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Lead Independent Director Ed Borkowski was the last independent director to join the board, commencing their role in 2015. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Dec 05+ 1 more updateGridAI Technologies Corp. Announces Board and Committee ChangesGridAI Technologies Corp. announced on November 28, 2025, Mr. Eric Corbett notified the Company of his resignation as a director of the company. On November 28, 2025, Mr. Richard Paolone notified the Company of his resignation as a director of the Company. Pursuant to the resignations of directors discussed in this Item 5.02, the committees of the Board of Directors of the Company shall comprise of the following: Audit Committee: (i) Ed Borkowski (Chair and Audit Committee Financial Expert); (ii) Manpreet Uppal; and (iii) Geordan G. Pursglove. Compensation Committee: (i) Ed Borkowski (Chair); (ii) Manpreet Uppal; and (iii) Geordan G. Pursglove.
お知らせ • Nov 18Entero Therapeutics, Inc. announced delayed 10-Q filingOn 11/17/2025, Entero Therapeutics, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.